Learn more

CYDEX PHARMACEUTICALS INC

Overview
  • Total Patents
    266
  • GoodIP Patent Rank
    15,161
  • Filing trend
    ⇧ 11.0%
About

CYDEX PHARMACEUTICALS INC has a total of 266 patent applications. It increased the IP activity by 11.0%. Its first patent ever was published in 2001. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and micro-structure and nano-technology are DEXTECH MEDICAL AB, SHIMODA BIOTECH PTY LTD and JUROX PTY LTD.

Patent filings per year

Chart showing CYDEX PHARMACEUTICALS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Pipkin James D 111
#2 Mosher Gerold L 95
#3 Machatha Stephen G 49
#4 Antle Vincent D 45
#5 Zimmerer Rupert O 44
#6 Thompson Diane O 42
#7 Cushing Daniel J 33
#8 Hecker Douglas B 28
#9 Johnson Karen T 27
#10 Wedel Rebecca L 23

Latest patents

Publication Filing date Title
AU2018263924A1 Composition containing cyclodextrin and busulfan
AU2017326519A1 Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin
WO2016149685A1 Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
AU2015255259A1 DPI formulation containing sulfoalkyl ether cyclodextrin
AU2015255164A1 Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
US2017275388A1 Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
US2014213650A1 Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
AU2014200085A1 Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
SG11201503089WA Alkylated cyclodextrin compositions and processes for preparing and using the same
AU2013201437A1 DPI formulation containing sulfoalkyl ether cyclodextrin
AU2013226073A1 Alkylated cyclodextrin compositions and processes for preparing and using the same
CN104271605A Manufacturing process for cyclodextrin derivatives
AU2011235943A1 Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
AU2011204957A1 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
AU2010253905A1 Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
KR20120026518A Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
US2009312724A1 Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions
US2009270348A1 Sulfoalkyl ether cyclodextrin compositions
US2009123540A1 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
WO2010053487A1 Composition containing sulfoalkyl ether cyclodextrin and latanoprost